IDSA Foundation
IDSA Foundation is the 501(c)(3) charitable arm of the Infectious Diseases Society of America, funding ID workforce development, mentorship, continuing education, and health equity programs through individual donations and a 14-partner pharmaceutical industry sponsorship program.
- Company typePrivate
- Founded-
- HeadquartersArlington, United States
- Headcount—
- GTM typeB2B and B2C
- OfferingServices
What IDSA Foundation does
IDSA Foundation is a 501(c)(3) nonprofit charitable organization (EIN 31-1765388) that operates as the dedicated philanthropic arm of the Infectious Diseases Society of America (IDSA), headquartered at 4040 Wilson Blvd., Suite 300, Arlington, Virginia. The foundation's mandate is to fundraise in support of IDSA's strategic priorities: strengthening the infectious diseases workforce, advancing inclusion and health equity in the ID field, and enhancing IDSA's capacity to lead in preparedness, research, and public health response. It serves three primary beneficiary segments — early-career ID professionals seeking mentorship and travel grants, practicing ID clinicians seeking continuing medical education, and underrepresented professionals in ID seeking growth opportunities — and is the institutional home of the Save HIV Funding advocacy coalition (founded 2023 with PrEP4All, AVAC, and HIVMA).
The foundation's product surface is a portfolio of programs rather than technology products. iDMentorship365 matches medical students, residents, and fellows with experienced ID mentors. IDWeek is the flagship annual ID conference co-hosted with IDSA and related societies. The Dr. John G. Bartlett Memorial Webinar Series delivers recurring virtual education on evolving ID topics such as the COVID-19 vaccine landscape. Workforce development includes travel grants for early-career professionals, while the Save HIV Funding Campaign (launched 2023) coordinates 150+ advocacy organizations and, per the foundation, helped stop nearly $2 billion in federal HIV funding cuts in fiscal year 2026. The foundation holds a Candid Platinum Seal of Transparency through 2026.
Revenue mechanics are split between individual philanthropic donations (one-time and recurring, processed through an integrated GoFundMe donation platform on idsafoundation.org and tax-deductible under U.S. law) and corporate/industry partnerships. The 2026 Industry Partners program lists 14 named sponsors: AbbVie, CSL Seqirus, AstraZeneca, Bayer, Gilead Sciences, GSK, Merck, Moderna, Novartis, Pfizer, QuidelOrtho, Sanofi, Shionogi, and ViiV Healthcare. Go-to-market is event-driven (IDWeek, Bartlett Series, iDMentorship365) and community-led, with marketing distributed across the ID Insights email newsletter, six social platforms (LinkedIn, Facebook, Instagram, Twitter/X, Threads, BlueSky), podcasts, and the foundation website. Financial figures — total contributions, headcount, and program-level budgets — are not publicly disclosed.
IDSA Foundation firmographics
Firmographics- Name
- IDSA Foundation
- Legal name
- IDSA Foundation
- Website
- https://idsafoundation.org
- Company type
- Private
- Operating status
- Operating
- Short description
- IDSA Foundation is the 501(c)(3) charitable arm of the Infectious Diseases Society of America, funding ID workforce development, mentorship, continuing education, and health equity programs through individual donations and a 14-partner pharmaceutical industry sponsorship program.
- Ownership category
- akta.pro rank
IDSA Foundation industry classification
Industry- Product category
- Nonprofit Healthcare Foundation - Infectious Diseases Professional Development
- NAICS
- Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
- akta.pro secondary industries
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Infectious Disease & Immunization Program Funding (HLAJALAH)
Keywords
Where IDSA Foundation is headquartered
LocationHeadquarters
- HQ city
- Arlington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
IDSA Foundation business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Philanthropic Donations: Individual donors contribute tax-deductible gifts to support ID workforce development, mentorship programs, and health equity initiatives. Donations can be one-time or recurring (monthly).
- Corporate/Industry Partnerships: Pharmaceutical and healthcare companies partner with the foundation through sponsorship arrangements, including 14 named industry partners in 2026 (AbbVie, CSL Seqirus, AstraZeneca, Bayer, Gilead, GSK, Merck, Moderna, Novartis, Pfizer, QuidelOrtho, Sanofi, Shionogi, ViiV Healthcare).
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
IDSA Foundation product offering
Product offeringCore offering
IDSA Foundation is the 501(c)(3) charitable arm of the Infectious Diseases Society of America, operating philanthropic programs that strengthen the ID workforce. Core offerings include the iDMentorship365 mentorship program connecting medical students, residents, and fellows with experienced ID mentors; travel grants and career development support for early-career professionals; the Dr. John G. Bartlett Memorial Webinar Series; and health equity initiatives for underrepresented professionals. The foundation is funded by tax-deductible individual donations and corporate industry partnerships with pharmaceutical and healthcare companies.
Product overview
IDSA Foundation is a 501(c)(3) charitable organization that serves as the primary fundraising partner of the Infectious Diseases Society of America. Rather than offering a unified technology product, the Foundation provides a portfolio of programs and initiatives including the iDMentorship365 mentorship program, the Bartlett Memorial Webinar Series, IDWeek annual conference, ID workforce development with travel grants, health equity initiatives, and the Save HIV Funding advocacy campaign. These offerings work together to strengthen the ID workforce, promote inclusion and diversity, and enhance IDSA's capacity in preparedness, research, and public health response.
Differentiator
Problem solved
Functional benefit
Products and services
- iDMentorship365 A mentorship program that connects medical students, residents, and fellows with experienced infectious diseases mentors and career resources to develop their passion for the ID specialty. Targeted at early-career ID professionals seeking career guidance.
- IDWeek Annual Conference Annual conference bringing together infectious diseases professionals for education, networking, and research presentations. Targeted at ID clinicians, researchers, and healthcare professionals.
- Dr. John G. Bartlett Memorial Webinar Series A named webinar series featuring educational content on evolving topics in infectious diseases, such as COVID-19 vaccine landscapes. Targeted at ID clinicians seeking continuing medical education.
- Save HIV Funding Campaign A coalition advocacy campaign launched in 2023 with PrEP4All and AVAC (and HIVMA) to protect federal HIV program funding and mobilize advocacy efforts against program cuts. Targeted at policymakers and the broader HIV advocacy community.
Quantifiable outcome
- Educates 1,000+ clinicians annually on timely ID care topics
- +1 more outcomes
Companies that use IDSA Foundation
Customer profileSegments3 records
Ideal customer profiles3 records
IDSA Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
IDSA Foundation partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered core.
- AbbViecorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- CSL SeqiruscoreVaccine company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- AstraZenecacorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- BayercorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- Gilead SciencescorePharmaceutical company partner specializing in HIV and viral diseases, supporting the IDSA Foundation's 2026 Industry Partnership program and related initiatives.
- GSKcorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- MerckcorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- ModernacoreBiotechnology company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- NovartiscorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- PfizercorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- QuidelOrthocoreDiagnostics company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- SanoficorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- ShionogicorePharmaceutical company partner of the IDSA Foundation's 2026 Industry Partnership program, supporting foundation initiatives in ID workforce development and health equity.
- ViiV HealthcarecoreSpecialty pharmaceutical company focused on HIV, partnered with the IDSA Foundation's 2026 Industry Partnership program supporting ID workforce and health equity initiatives.
- PrEP4AllcoreCo-founder of the Save HIV Funding campaign along with AVAC and HIVMA. The campaign has grown to 150+ organizations and stopped nearly $2 billion in HIV funding cuts.
- AVACcoreCo-founder of the Save HIV Funding campaign along with PrEP4All and HIVMA. Campaign focuses on protecting federal HIV program funding.
- HIVMAcoreCo-founder of the Save HIV Funding campaign along with PrEP4All and AVAC. Joint fundraising effort with IDSA Foundation to protect federal HIV funding.
- IDSA (Infectious Diseases Society of America)coreThe foundation is the 501(c)(3) charitable arm of IDSA and serves as the primary fundraising partner advancing IDSA's strategic priorities.
- IDWeekcoreAnnual ID conference co-hosted/associated with the foundation, providing platform for education and foundation engagement.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
IDSA Foundation competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key highlights6 records
Customer concentration
IDSA Foundation social profiles
Digital presenceIDSA Foundation compliance and trust
Trust signalCompliance2 records
IDSA Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
IDSA Foundation leadership team
Management profileNumber of profiles
IDSA Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IDSA Foundation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IDSA Foundation
What does IDSA Foundation do?
IDSA Foundation is the 501(c)(3) charitable arm of the Infectious Diseases Society of America, operating philanthropic programs that strengthen the ID workforce. Core offerings include the iDMentorship365 mentorship program connecting medical students, residents, and fellows with experienced ID mentors; travel grants and career development support for early-career professionals; the Dr. John G. Bartlett Memorial Webinar Series; and health equity initiatives for underrepresented professionals. The foundation is funded by tax-deductible individual donations and corporate industry partnerships with pharmaceutical and healthcare companies.
Is IDSA Foundation a public or private company?
IDSA Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was IDSA Foundation founded?
IDSA Foundation was founded in -1.
Where is IDSA Foundation based?
IDSA Foundation is headquartered in Arlington, United States, in the North America region.
How does IDSA Foundation make money?
Two revenue lines are on record. Philanthropic Donations are the primary driver. The others are corporate/Industry Partnerships.
Does IDSA Foundation have an API?
No public API is recorded for IDSA Foundation.
What industry is IDSA Foundation in?
IDSA Foundation's product category is Nonprofit Healthcare Foundation - Infectious Diseases Professional Development. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8600.